Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Times Interest Earned (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Times Interest Earned for 13 consecutive years, with -$3.52 as the latest value for Q4 2025.

  • Quarterly Times Interest Earned fell 123.94% to -$3.52 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.21 through Dec 2025, down 126.24% year-over-year, with the annual reading at -$2.11 for FY2025, 572.1% down from the prior year.
  • Times Interest Earned for Q4 2025 was -$3.52 at Aytu Biopharma, down from -$2.91 in the prior quarter.
  • The five-year high for Times Interest Earned was $2.69 in Q1 2025, with the low at -$10.44 in Q2 2025.
  • Average Times Interest Earned over 3 years is -$1.8, with a median of -$1.42 recorded in 2024.
  • Peak annual rise in Times Interest Earned hit 311.73% in 2025, while the deepest fall reached 475.64% in 2025.
  • Over 3 years, Times Interest Earned stood at $2.48 in 2023, then crashed by 163.22% to -$1.57 in 2024, then plummeted by 123.94% to -$3.52 in 2025.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$3.52, -$2.91, and -$10.44 for Q4 2025, Q3 2025, and Q2 2025 respectively.